• Daily News
  • Weekly News
  • Special Editions
  • Oil and Gas Events
  • Key Economic Indicators
  • Other Services
Country List
  • Algeria
  • Bahrain
  • Egypt
  • Iran
  • Iraq
  • Kuwait
  • Libya
  • Oman
  • Qatar
  • Saudi Arabia
  • UAE
  • Yemen
  • General News
PAM
  • Project Activity Monitoring
  • Company Activity Monitoring

For Free Headlines Submit Your Email

Login  

Friday, May 9, 2025 23:3 GMT

  • Home
  • About Us
  • Archive
  • Contact Us

News

Iran to Produce Three New Human Vaccines by Yearend: Official


The Secretary of Biotechnology Development Headquarters of the Vice-Presidency for Science and Technology said that three new human vaccines will be produced in the country by yearend (March 20). Mostafa Ghane'ie  broke the news on Sat. and reiterated that three human vaccines will be unveiled before the end of 1399 (March 2020-21). “We have decided to add three new human vaccines to the list of domestically-produced vaccines by the yearend,” Ghane'ie  added. Presently, public sector has not thus far managed to produce these vaccines since they consume high currency valuation. Elsewhere in his remarks, he pointed out that six accelerators have thus far been created in the country in the field of vaccine. Presently, Islamic Republic of Iran has stood at the first rank in the West Asia in terms of biotechnology and vaccine production and is among top five producers of biotechnology products in Asia, Secretary of Biotechnology Development Headquarters of the Vice-Presidency for Science and Technology Ghane'ie  added. - Mehr


published:09/11/2020 04:50 GMT

Related News

  • Iranian-Made COVID-19 Vaccine to Enter Human Trial in Early November  22/10/2020 05:18 GMT
  • Iran, Russia Discussing Joint Production of Covid-19 Vaccine: ...  27/09/2020 05:22 GMT
  • Company to Release First Iran-Made Flu Vaccine  10/02/2020 09:18 GMT
  • Iranian-Made HPV Vaccine to be Commercialized in Months  30/01/2020 05:52 GMT

© 2025 BEDigest. All Rights Reserved.

to read more about this project please go to